Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping-Reference-Cited by-同舟云学术

Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping

Published:2021-02 Issue:2 Volume:23 Page:210-221
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Khera Eshita^ORCID,Cilliers Cornelius,Smith Michael D.^ORCID,Ganno Michelle L.,Lai Katharine C.,Keating Thomas A.,Kopp Anna,Nessler Ian^ORCID,Abu-Yousif Adnan O.^ORCID,Thurber Greg M.^ORCID

Funder

Takeda Pharmaceuticals North America

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research

Reference66 articles.

1. Pharmacokinetic and immunological considerations for expanding the therapeutic window of next-generation antibody-drug conjugates;Khera;BioDrugs,2018

2. Strategies and challenges for the next generation of antibody-drug conjugates;Beck;Nat Rev Drug Discov,2017

3. Driving CARs on the uneven road of antigen heterogeneity in solid tumors;Chen;Curr Opin Immunol,2018

4. Determination of ADC cytotoxicity in immortalized human cell lines;Wu,2020

5. Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates;Lu;Nat Commun,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?;Cancer Treatment Reviews;2024-09

2. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08

3. Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload;Xenobiotica;2024-07-17

4. Sustained and Localized Drug Depot Release Using Radiation‐Activated Scintillating Nanoparticles;Advanced Materials;2024-03-08

5. What influences the activity of Degrader−Antibody conjugates (DACs);European Journal of Medicinal Chemistry;2024-03